InvestorsHub Logo
Followers 5
Posts 159
Boards Moderated 0
Alias Born 01/15/2015

Re: None

Tuesday, 04/25/2017 7:03:20 AM

Tuesday, April 25, 2017 7:03:20 AM

Post# of 111920
Updated P/S calculations: VPOR hugely undervalued compared to its peers

Now that the financials for 2016 are out I updated my previous calculations of price-to-sales -ratio for VPOR and some of its peers. The P/S for VPOR is currently around 2, when other marijuana companies seem to have it around 30.
If VPOR's P/S was the same as AC$L's, our PPS would be 13,6 times higher than it currently is, trading at about 2,7 cents. Compared to the others it should be even higher.

Of course these calculations are based on my estimations of what each company's revenues for 2017 would be, but in my opinion my estimations are plausible. And the P/S ratio doesn't tell the whole truth, but this kind of a huge gap between VPOR and the others at least gives us a hint of the direction where we should start heading, and it's not down.

See for yourself and tell me what you think. If you have an idea for an additional company for comparison, tell me about it too.